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Bioprinting Using Mechanically 
Robust Core–Shell Cell-Laden 
Hydrogel Strands
P. Mistry, A. Aied, M. Alexander,  
K. Shakesheff, A. Bennett, J. Yang* 
Combining good biological and mechan-
ical properties in bioprinted constructs 
is desirable for them to be employed in 
many tissue engineering and regenera-
tive medicine applications. Bioprinted cell-
laden constructs with core–shell strands 
have been developed. The cell-supporting 
materials in the core support high cell via-
bility and tissue-like functions while the 
shell material offers mechanical robust-
ness to the bioprinted constructs.
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The strand material in extrusion-based bioprinting determines the microenvironments 
of the embedded cells and the initial mechanical properties of the constructs. One unmet 
challenge is the combination of optimal biological and 
mechanical properties in bioprinted constructs. Here, a novel 
bioprinting method that utilizes core–shell cell-laden strands 
with a mechanically robust shell and an extracellular matrix-
like core has been developed. Cells encapsulated in the strands 
demonstrate high cell viability and tissue-like functions during 
cultivation. This process of bioprinting using core–shell strands 
with optimal biochemical and biomechanical properties repre-
sents a new strategy for fabricating functional human tissues 
and organs.
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1. Introduction
The development of highly organized and functional 3D 
tissue constructs remains an unmet challenge. Bioprinting 
is emerging as a promising technology for recapitu-
lating 3D hierarchical tissue/organ structures comprising 
multiple cell types and extracellular matrix (ECM). For bio-
printed constructs to survive and function during in vitro 
Q2 maturation, particularly where mechanical stimulation is 
applied, and after implantation, both the biological and 
mechanical properties of bioprinted tissue constructs are 
critical. Hydrogels that are widely used to encapsulate cells 
in bioprinting, therefore, are required to offer tailored bio-
logical and mechanical properties to support the survival 
and functions of encapsulated cells and maintain the initial 
structural integrity of the 3D constructs. Despite significant 
advances in bioprinting of tissues and organs, the com-
bination of optimal biological and mechanical properties 
in bioprinted cell-laden hydrogel constructs has not been 
achieved. In this paper, we describe a novel extrusion-based 
bioprinting process that utilizes core–shell cell-laden strands 
with a mechanically robust hybrid hydrogel shell and an 
ECM-mimicking hydrogel core. The ECM-mimicking hydro-
gels, such as collagen and Matrigel, supported high cell via-
bility and in vivo like cell functions, meanwhile the hybrid 
hydrogel shell supplied mechanical robustness, such as 
shape recovery after compression. Three different cell types 
were encapsulated in bioprinted structures consisting of 
core–shell strands, all of which displayed high cell viability 
during culture. A vascular-like morphology from the human 
umbilical vein endothelial cells (HUVECs) and albumin 
secretion by HepG2 cells in the core were demonstrated. The 
release rates of two proteins from the strands were found to 
Macromol. Biosci. 2017, DOI: 10.1002/mabi.201600472
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correlate with the rate of swelling. These core–shell strands 
can be used to fabricate hierarchical tissue constructs with 
desirable biological and mechanical properties.
Since the early work in which a microfluidic device was 
used to make continuous solid and hollow fibers,[1] a body 
of work has been published on cell-laden hydrogel fibers/
strands with different configurations (solid, hollow, and 
core–shell configurations) formed by using microfluidic 
devices[1–7] as well as extrusion through coaxial 
needles.[8–12] To form 3D structures, bioprinting utilizing 
coaxial needles has been used to fabricate structures with 
solid,[7,13] hollow strands,[10,11] and core–shell strands.[14,15] 
However, the materials used in the coaxial bioprinting 
have not been optimized for optimal cell viability/func-
tion and mechanical robustness of the printed constructs. 
Alginate has been used in these bioprinting processes 
due to its rapid gelation when encountering multivalent 
cations. However, alginate lacks cell-binding sites for sup-
porting cell spreading,[16] which resulted in suboptimal 
cell viability and function in these bioprinted constructs 
with cell-laden solid or hollow strands. To create an ECM-
like microenvironment for encapsulated cells, core–shell 
fibers with an ECM protein core and an alginate shell 
have been shown to support the long-term culture of 
encapsulated cells; these cells exhibited tissue-like mor-
phologies and functions.[6] A purpose-built microfluidic 
weaving machine was used to assemble these core–shell 
fibers into higher-order structures.[6] However, the ability 
to fabricate complex 3D geometries using the textile 
manufacturing technology is limited. Moreover, alginate 
hydrogels are relatively brittle and lack flexibility for in 
vitro manipulation and implantation. The strategy of 
combining hydrogels has been found to markedly improve 
the mechanical properties.[17–19] However, those hydrogels 
were made using harsh conditions which inhibited the 
encapsulation of cells. Recently, a hybrid hydrogel pre-
pared under cell-compatible conditions has been used to 
encapsulate cells, and subsequently it has been 3D printed 
into various cellular 3D geometries.[18] While improved 
toughness and the ability to recover its shape after com-
pression were achieved, the hybrid hydrogel lacked the 
biological properties for optimal cell survival and func-
tion. Despite these significant advances in bioprinting 
using cell-laden strands, one remaining challenge is the 
bioprinting of tissue-relevant architectures using strands 
with combined optimal biological and mechanical proper-
ties. Here we have developed a novel bioprinting method 
that utilizes core–shell cell-laden strands, which have a 
mechanically robust shell and an ECM-like core to achieve 
both optimal biological and mechanical properties.
In our approach, the core–shell strands were bioprinted 
using a coaxial needle mounted onto a commercial 3D 
printer (Figure 1A,B). Bioprinting using a coaxial needle 
was chosen because the core and the shell materials 
formed a composite strand which combined the 
cell-supporting and the mechanical properties of the core 
and the shell, respectively. The central nozzle was per-
fused with a cell-laden hydrogel, while the outer nozzle 
was perfused with a partially crosslinked alginate or a 
hybrid hydrogel comprising alginate and poly(ethylene 
glycol) diacrylate (PEGDA). The partial crosslinking gave 
alginate and the hybrid gel solutions a suitable viscosity 
range (Figure 1C) for the formation of a continuous strand 
during the extrusion-based bioprinting process (Movie S1, 
Supporting Information). 17 × 10−3 m calcium chloride was 
found to generate a viscosity range that is suitable for 
the printing of both alginate and hybrid gels. Addition of 
PEGDA to alginate resulted in an increase in viscosity. How-
ever, both the partially crosslinked alginate and hybrid gels 
showed similar viscosities (Figure 1C), which suggests that 
the viscosity of the printable gels was mainly determined 
by the crosslinking caused by calcium ions. The partial 
crosslinking of the alginate shell eliminated the need to 
use highly concentrated alginate[10] to achieve a suitable 
viscosity for printing, as well as the requirement to co-
perfuse highly concentrated calcium chloride in the core to 
form alginate strands.[7,11,13] The core–shell configuration 
also allowed for the inclusion of cell-laden collagen and 
Matrigel, which are usually too fluidic for shape fixation 
via the extrusion-based bioprinting method. The core–shell 
configuration of the printed strands was well defined with 
the cellular core positioning approximately in the center 
of the strands (Figure 1D). Cell-laden strands were printed 
into thick multilayered constructs that would not be pos-
sible to fabricate using textile manufacturing methods 
(Figure 1E,F). We noticed that the partially crosslinked 
hydrogels were relatively soft, which consequently compro-
mised the interconnectivity of pores during printing. This 
was due to the sinking of strands that were printed above a 
layer where the gaps between the two supporting strands 
were wide. Therefore, a coprinting method was devel-
oped in which gelatine strands were printed in the gaps 
between the core–shell strands for supporting, and sub-
sequently removed by incubating in cell culture medium 
at 37 °C (Movie S2, Supporting Information). A 20-layered 
construct was made using this method (Figure 1E). By 
immersing the coprinted constructs in a calcium chloride 
solution and subsequently in culture medium at 37 °C, 
gelatine was removed efficiently and the shape was main-
tained (Figure 1F). Imaging the cross section (side view of 
the constructs) using scanning electron microscopy (SEM) 
after the removal of gelatine showed that the pores were 
open and interconnected (Figure 1G).
When a hybrid gel (PEGDA/alginate) was used as the 
shell material, each layer of a multilayer construct was 
crosslinked using UV before the next layer was printed on 
top in order to ensure the uniform crosslinking of PEGDA. 
Repeated UV exposure during the printing of thick 
Q3
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constructs was found to lower cell viability, which was 
caused by the penetration of UV light into lower layers 
during crosslinking of the top layer (Figure 1H). We there-
fore replaced the UV-activated photoinitiator (Irgacure 
2959) with a visible-light-activated photoinitiator (lithium 
phenyl-2,4,6-trimethyl-benzoylphosphinate (LAP)).[20,21] 
Cells encapsulated in the visible-light-crosslinked meth-
acrylated gelatine (GelMA) showed high viability, even 
after long exposure to the light (Figure 1I). Tall Cell-laden 
constructs could therefore be printed without compro-
mising the viability of cells (Movie S3, Supporting Infor-
mation). Although the strand diameter (ca. 800 µm) was 
greater than those made using microfluidic devices 
(ca. 200 µm), high cell viability was maintained during 
culturing (Figure 2), suggesting that transportation of 
nutrients and oxygen was sufficient through the shell to 
the cellular core.
To investigate cell survival, morphology, and func-
tion within the bioprinted structures constructed from 
core–shell strands, three different cell types were sepa-
rately encapsulated in three different core materials. The 
combinations of cell type and core hydrogel (gelatine 
methacrylate, collagen, Matrigel) is shown in Figure 2A. 
High cell viabilities were maintained during the culture 
period of 28 d. 3T3 fibroblast culture was terminated at 
day 7 due to the rapid proliferation and consequent con-
fluence of cells. The cell viabilities between constructs 
with alginate or the hybrid gel (9:2, PEGDA: alginate 
Macromol. Biosci. 2017,  DOI: 10.1002/mabi.201600472
Figure 1. 3D bioprinting using core–shell cell-laden strands. A,B) Schematic diagram depicting the coaxial needle and the printer assembly. 
C) Viscosities of uncrosslinked and partially crosslinked alginate and hybrid gels. D) A 3D printed lattice comprised of core–shell (hybrid 
gel) stands with fluorescently labelled cells in the core surrounded by the shell (darker gray). The inset is a bright-field image showing the 
core and shell. Scale bar: 1 mm. E) A bioprinted 20-layer construct using coprinting of cell-laden core–shell (hybrid gel) strands and gelatine 
strands. Scale bar: 10 mm. F) A printed construct after removal of gelatine showing structural integrity. G) SEM image of the cross section 
(side profile) of a bioprinted construct showing interconnected pores after the removal of gelatine. Scale bar: 1 mm. H) Viability of 3T3 
fibroblasts in a six-layer construct with 1 min UV exposure for each layer. The construct was manually cut into five layers from base to top 
for viability evaluation. I) Viability of 3T3 fibroblasts after exposure to visible light for different time periods. Error bars represent standard 
deviation, n = 3.
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(%)) shell were similar. Immediately after printing, the 
HUVECs appeared discrete and rounded, and were a mix-
ture of individual cells and cell aggregates. The HUVECs 
began to spread in the Matrigel core by day 1, and had 
organized themselves to form a vascular-like structure by 
day 7. This vascular-like structure was maintained from 
day 7 to day 28. HUVECs were cultured up to 44 d, and 
showed high cell viability (Figure S1, Supporting Informa-
tion). On day 44 of the HUVEC culture, the strands were 
cut transversely to image the cross sections. The forma-
tion of a vascular-like structure within the strands was 
observed (Figure 2C). It appeared that the vascular-like 
channels were formed at the boundary between the core 
and the shell (Figure S1, Supporting Information), sug-
gesting that it is possible to control the diameter of the 
channel by varying the size of the central needle. The 
embedded HepG2 cells exhibited an increase in albumin 
secretion over time (Figure 2D), which correlated with the 
increase in cell numbers as evidenced in Figure 2B.
We have also demonstrated that two different cell types 
can be coprinted into the core and shell, respectively. 
Figure 2E shows the bioprinted strands with hepato-
cytes in the alginate shell and HUVECs in the Matrigel 
core. After 7 d of cultivation, the HUVECs in the core 
formed a vascular-like structure, similar to that formed 
in the strands with an acellular shell (Figure 2F). HepG2 
cells in the alginate shell formed multiple cell aggre-
gates. Although the channels formed by the HUVECs are 
larger than liver sinusoids, this bioprinted multicellular 
structure is representative of the natural arrangement of 
endothelial cells and hepatocytes in liver. The capability of 
including two cell types in the core and shell, respectively, 
suggests the possibility of fabricating vascularized mini-
tissues using these core–shell strands. The cell type in 
the shell can potentially be changed, implying that these 
core–shell strands can be used to fabricate different vascu-
larized mini tissues.
Next, we measured the tensile properties of algi-
nate/PEGDA hybrid gels with different compositions. 
Three hybrid gel compositions (namely 10:1, 9:2, and 
8:3, PEGDA:alginate (%)) were examined while the 
overall hybrid gel concentration was fixed at 11% (w/v). 
The tensile properties of these materials were assessed 
using molded dumbbell-shaped samples, and are shown 
in Figure 3A. Representative stress–strain curves are 
shown in Figure S2 in the Supporting Information. The 
modulus and ultimate tensile strength (UTS) of the hybrid 
gels increased with the concentration of alginate. The 
strengths of the hybrids were much higher than the sums 
of the individual components, suggesting a synergistic 
effect (Figure S3, Supporting Information). This syner-
gistic effect is likely due to the entanglement of alginate 
Macromol. Biosci. 2017,  DOI: 10.1002/mabi.201600472
Figure 2. Cell viability, morphology, and function within bioprinted constructs with core–shell strands. A) Viability of three different cell 
types in the core–shell strands with different core and shell materials. B) Cell morphologies in the cores of core–shell strands during 28 d 
of culturing. Cells were labelled using green-fluorescent calcein-AM (live cells) and red-fluorescent ethidium homodimer-1(dead cells). 
C) Formation of a vascular-like structure from bioprinted HUVECs in a transversely cut core–shell strand at day 44. Scale bar = 100 µm. 
(D) Albumin secretion of HepG2 cells in bioprinted constructs. E,F) Bioprinted HUVECs and HegG2 cells in the core and shell respectively at 
day 0 and day 7. The cells were fluorescently labelled at day 0 using a red and a green cell tracker, respectively. Scale bar: 200 µm. Error bars 
represent standard deviation, n = 3.
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and PEGDA chains; chain entanglement in hydrogels is a 
contributor to their mechanical properties.[22] The 9:2 and 
8:3 hybrid gels showed an increase in all three mechanical 
properties (modulus, UTS, and failure strain) compared to 
pure alginate gels, with a maximum 65% increase in UTS 
for the 8:3 hybrid gels (Table S1, Supporting Information). 
Up to 3% alginate was used in our study. While higher con-
centrations can further increase the modulus and strength 
of gels, they can also reduce the transportation of nutri-
ents[23–25] and cell viability.[26,27] Both PEGDA and alginate 
have been tested in clinical trials and have shown good 
biocompatibility.[28,29] In this study, we have used calcium 
chloride to replace the low-solubility calcium sulfate used 
in previous studies,[18] eliminating the presence of solid 
calcium sulfate particles in the final printed constructs. 
Though calcium sulfate was shown to be biocompatible 
as a bone substitute in animal testing,[30] its presence may 
not be desirable in other applications. Bioprinted solid con-
structs with cell-laden core–shell strands were assessed 
using compression testing. The constructs were com-
pressed to 50% of their original height and then released 
immediately. The printed constructs with the hybrid gel 
(9:2, PEGDA:alginate (%)) showed significantly more shape 
recovery compared to pure alginate counterparts.
The degradation of the core and shell materials used in 
our study has been previously reported. The core mate-
rials (collagen I, Matrigel, GelMA) are likely to degrade 
faster than the shell materials (PEGDA and alginate) due 
to enzymatic degradation of these protein-based mate-
rials.[31–33] The degradation of PEGDA has been attributed 
to the hydrolysis of the esters rather than the backbone 
ethers.[34] The modulus of PEGDA, which was implanted 
Macromol. Biosci. 2017,  DOI: 10.1002/mabi.201600472
Figure 3. Mechanical properties and protein release properties of bioprinted constructs. A) Tensile properties of dumbbell-shaped hydrogels. 
B) Shape changes of bioprinted ten-layered solid constructs with cell-laden core–shell strands after compression to 50% strain. C) Quanti-
fied shape recovery using the percentage of initial height after compression. D) Human IgG and human insulin release profiles from printed 
constructs with core–shell strands. Error bars represent standard deviation, n = 3. The * sign denotes statistical difference using α = 0.05.
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in a rat, showed progressive reduction at an average rate 
of 6% per week. Degradation of alginate relies on the 
gradual exchange of calcium, which crosslinks guluronic 
acid blocks, for monovalent cations.[35] Oxidation can 
also be used to make alginate degradable under physi-
ological conditions.[36] The difference in degradation rates 
means that the remodeling processes in the core and the 
shell, respectively, are different. The shell material would 
remain longer than the core material after implantation, 
which is beneficial for maintaining structural stability.
These core–shell strands can potentially be used for 
immunoprotective roles to encapsulate allogenic cells or 
for delivering therapeutic proteins. To test the release of 
proteins from the strands, two proteins of different sizes 
were studied: human insulin (6.6 kDa) and human IgG 
(150 kDa). Figure 3D shows the release profiles of proteins 
from the bioprinted constructs with core–shell strands. 
The results show no significant differences between the 
hybrid shell and the pure alginate shell, suggesting that 
the addition of crosslinked PEGDA does not reduce the 
overall mesh size significantly, with regard to the sizes 
of the investigated proteins. The cumulative release of 
insulin is greater than that of IgG, suggesting that higher-
molecular-weight proteins are more likely to be entrapped 
within the gels. The times at which the protein releases 
started to plateau were similar to the time (11 h) at which 
the swelling reached maximum (Figure S4, Supporting 
Information), suggesting the rapid release may be related 
to the increase of hydrogel mesh size caused by swelling. 
The rate of protein release agrees with previous observa-
tions made on protein release from alginate beads.[37,38]
In summary, we have bioprinted 3D structures with 
core–shell strands that have a mechanically robust shell 
and an ECM-mimicking core. Interconnected pores were 
introduced by using a coprinting process. Bioprinting 
using the core–shell hydrogel strands allows more com-
plex 3D geometries to be formed compared to textile 
manufacturing methods. Compared to previous coaxial 
bioprinting, the materials we employed enhanced the 
mechanical robustness of the constructs, and the survival 
and function of encapsulated cells. Separately encapsu-
lated, three cell types in the core showed high viability 
within bioprinted constructs consisting of core–shell 
strands. The formation of a tissue-like morphology by 
the HUVECs was also observed. In addition, we were able 
to coprint endothelial cells in the core and HepG2 cells 
in the shell to fabricate mini tissues with vascular-like 
structures, which can potentially be assembled to form 
larger and more complex tissues using bioprinting. By 
adding PEGDA to alginate, the hybrid gels showed greater 
tensile moduli and strengths compared to pure alginate. 
The shape recovery after compression was also signifi-
cantly improved by using hybrid gel strands. The rates 
of protein diffusion through the alginate and hybrid gel 
shell showed no difference. This process of bioprinting 
using core–shell strands with combined biochemical and 
biomechanical properties represents a new strategy for 
fabricating functional human tissues and organs.
2. Experimental Section
2.1. 3D Bioprinting with Core–Shell Strands
Constructs with core–shell strands were printed using a 
coaxial needle (27G/18G inner and outer needles, respectively) 
mounted onto a commercial 3D bioprinter (RegenHU, Switzer-
land). The core and shell were driven by two separate syringe 
pumps using flow rates of 0.01 and 0.1 mL min−1, respec-
tively. Hydrogel solutions for the shell were prepared by dis-
solving either PEGDA (20 kDa; Sigma-Aldrich) or alginate (FMC 
Biopolymer) individually, or in combination, in deionized water 
at the desired (w/v) concentrations. For the hybrid hydrogels, 
the total hydrogel concentration was fixed at 11% (w/v). Irga-
cure 2959 (I2959; Sigma-Aldrich) or LAP (TCI Chemicals) was 
added as the photoinitiator at a final concentration of 0.1% or 
0.13% (w/v), respectively, in the hybrid gel solutions. The shell 
hydrogel solutions were partially crosslinked by mixing with 
calcium chloride solutions to reach a final concentration of 
17 × 10−3 m calcium ions. For strands with the LAP photoinitiator, 
visible light (Schott KL1500 LCD) was shone continuously during 
printing; for strands with the I2959 photoinitiator, UV (power: 
15 W; λ: 365 nm; working distance: 35 mm; UVP Cambridge, 
UK) was shone for 1 min per layer during printing. These con-
structs were then immersed in a calcium containing buffer 
(100 × 10−3 m CaCl2, 150 × 10−3 m NaCl, 25 × 10−3 m HEPES, phenol 
red indicator, deionized water, pH 7.5) for 10 min. The core 
materials of collagen (Corning) and Matrigel (BD Bioscience) 
were printed at 5 °C to prevent crosslinking in the cartridge. 
Type I rat tail tendon collagen was used at a concentration of 
3 mg mL−1. GelMA was prepared as described previously,[39] 
and 5% (w/v) GelMA in culture medium was used. Four mil-
lion cells per milliliter were used as the cell density in all cores. 
6% (w/v) gelatine was used in the coprinting process.
2.2. Formation of Dumbbell-Shaped Hydrogel Samples
All gels were cast in a dumbbell-shaped PTFE mold. The samples 
had a thickness of 3 mm and a length of 10 mm for the reduced 
section. If PEGDA was included, the hydrogel solutions were first 
cured with UV for 2 min before the crosslinking of alginate in a 
CaCl2 solution (100 × 10−3 m) for 10 min. Pure alginate hydrogels 
were prepared by first pre-crosslinking with a CaSO4 slurry at a 
fixed alginate:CaSO4 ratio of 1:0.1328. The solution was immedi-
ately cast into the mold and left for 5 min with a glass slide to 
cover the top. The pure alginate hydrogels were then immersed 
in a 100 × 10−3 m CaCl2 bath for 10 min.
2.3. Tensile and Compression Testing of Hydrogels
The tensile properties the hydrogels were measured at room 
temperature using a Universal Texture Analyser (TA-HD Plus, 
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Stable Microsystems, USA). The grip section of each dumbbell-
shaped gel was wrapped with paper towel to improve gripping. 
A constant deformation speed of 0.5 mm s−1 was applied during 
the test. The tests were stopped after the samples broke. Com-
pression testing was carried out using the same machine on 
bioprinted solid constructs (8 × 8 × 8 mm3, ten layers) with cell-
laden core–shell strands.
2.4. Cell Culture
All cells were cultured at 37 °C with 5% CO2. HepG2 cells 
(ATCC) were used up to passage 20, and were cultured in 
Eagle’s minimal essential medium (Sigma-Aldrich) supple-
mented with 9% (v/v) fetal bovine serum (FBS; Sigma-Aldrich), 
2 × 10−3 m l-glutamine (Sigma-Aldrich), 1% nonessential amino 
acids (Gibco), and 1% antibiotic/antimycotic (Sigma-Aldrich). The 
3T3 mouse fibroblast (3T3) cell line (ATCC) was used up to pas-
sage 65, and were cultured in DMEM supplemented with 9% FBS, 
2 × 10−3 m l-glutamine, and 1% antibiotic/antimycotic. Primary 
HUVECs (PromoCell) were used up to passage 6, and were cul-
tured in endothelial cell basal medium (PromoCell).
2.5. Cell Viability and Albumin Secretion
Cell viability was measured using a live/dead kit (ThermoFisher, 
UK). To measure cell viability in LAP crosslinked GelMA, one mil-
lion cells per milliliter of 3T3 fibroblasts were encapsulated in 
5% (w/v) GelMA containing 0.13% (w/v) LAP. Light (working dis-
tance: 25 mm) was shone on the gels for different time periods, 
after which culture media was added.
Fluorescent images were taken using a fluorescence micro-
scope (Leica). The albumin secretion was measured using an 
ELISA kit (Abcam, UK) and a plate reader (Infinite M200, Tecan).
2.6. Protein Release Studies
Lattice constructs (20 × 20 × 1.6 mm3, two layers) were printed 
with a core of GelMA (5%) loaded with either recombinant 
human insulin (Sigma-Aldrich) or recombinant human IgG 
(Sigma-Aldrich). The concentrations of insulin and IgG in the 
cores were 174 and 10 µg mL−1 respectively. Constructs were 
incubated in culture medium at 37 °C. At regular intervals, the 
medium was taken and replaced with fresh medium. ELISA was 
used to examine the medium samples for the presence of insulin 
(Simple-Step Human Insulin ELISA; Abcam) or IgG by (Human 
IgG ELISA; Sigma-Aldrich).
2.7. Statistical Analysis
One-way ANOVA with Tukey’s posthoc test was used for statis-
tical analysis. An α value of 0.05 was used in both methods.
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